Exane Derivatives Health Catalyst, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Exane Derivatives holds 43 shares of HCAT stock, worth $349. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43
Previous 43
-0.0%
Holding current value
$349
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding HCAT
# of Institutions
170Shares Held
49.7MCall Options Held
2.86MPut Options Held
56.4K-
Black Rock Inc. New York, NY5.43MShares$44.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.58MShares$37.2 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN4.3MShares$34.9 Million3.05% of portfolio
-
Impax Asset Management Group PLC2.55MShares$20.8 Million0.09% of portfolio
-
Daventry Group, LP New York, NY2.42MShares$19.7 Million7.83% of portfolio
About Health Catalyst, Inc.
- Ticker HCAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 54,723,400
- Market Cap $445M
- Description
- Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...